The shift away from M2 macrophages suggests that KRAS activation combined with chronic infection promotes a more inflammatory M1-like phenotype, which may have both tumor-promoting and tumor-suppressive effects depending on the stage of carcinogenesis. Here, KRAS is linked to neoplasm.